Clinical Trial Materials

>

Latest News

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Pluri’s CDMO Business to Manufacture Cell Therapy Candidates from Kadimastem

July 19th 2024

Pluri’s newly launched CDMO business will manufacture two novel cell therapy product candidates for Kadimastem.

Cagkan - stock.adobe.com
eXmoor pharma Expands into Full-Service Cell and Gene Therapy CDMO Partner with Opening of GMP Facilities

October 12th 2023

Cagkan - stock.adobe.com
Vaxxas Opens Manufacturing Facility for Clinical Trials and Commercial Products

June 20th 2023

IRBs Need More Monitoring

February 23rd 2023

Boehringer Ingelheim, 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

January 13th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.